A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Given the relationship between the presence of ApoE epsilon 4 and Alzheimer's disease (AD), were studied whether knowledge of epsilon 4 status would predict which memory-impaired patients would develop AD over time. One hundred seven patients who presented with memory impairment but not dementia were referred to the study by their family physicians. These patients were followed prospectively over a 2-year period. Twenty-nine patients developed AD, while 78 did not develop dementia. We found that ApoE genotype was a reliable prognostic indicator of who developed AD in this group only when memory test performance was included in the predictive model. These findings indicate that limitations of ApoE genotyping in isolation as a prognostic indicator of AD. Because this study included prospectively selected patients who were followed longitudinally, our findings are likely to have more relevance in the clinical setting than those obtained from currently available retrospective studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802
Cited by
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Self-citationPetersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065
“In another Class II Canadian study from a similar setting in Toronto, 107 subjects with a memory impairment without dementia were followed for 2 years.(14,15) Subjects were referred to the study by family physicians, and the mean age of the subjects was 74 years.”
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Reitz, C., & Mayeux, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.024 · Cited by 1,181
Petersen, R. C. (2016) · Continuum · doi:10.1212/con.0000000000000313 · Cited by 909
Aging, Memory, and Mild Cognitive Impairment
Petersen, R. C., Kokmen, E., Waring, S. C., Smith, G. E., Ivnik, R. J., & Tangelos, E. G. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004717 · Cited by 888
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis
Bäckman, L., Jones, S., Berger, A.-K., Laukka, E. J., & Small, B. J. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.4.520 · Cited by 735
Tariq, S. H., Tumosa, N., Chibnall, J. T., Perry, M. H., & Morley, J. E. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000221510.33817.86 · Cited by 724
Mild Cognitive Impairment:An Overview
Petersen, R. C., & Negash, S. (2008) · CNS Spectrums · doi:10.1017/s1092852900016151 · Cited by 667
Computerized Cognitive Training with Older Adults: A Systematic Review
Kueider, A. M., Parisi, J. M., Gross, A. L., & Rebok, G. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040588 · Cited by 656
Praticò, D., Clark, C. M., Liun, F., Lee, V. Y.-M., & Trojanowski, J. Q. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.972 · Cited by 584
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
DeCarli, C. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00262-x · Cited by 573
Pathways linking late-life depression to persistent cognitive impairment and dementia
Butters, M. A., Young, J. B., Lopez, O., Aizenstein, H. J., Mulsant, B. H., Reynolds III, C. F., DeKosky, S. T., & Becker, J. T. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.3/mabutters · Cited by 534
Morris, J. C., & Price, J. L. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:101 · Cited by 513
Devanand, D. P., Liu, X., Tabert, M. H., Pradhaban, G., Cuasay, K., Bell, K., de Leon, M. J., Doty, R. L., Stern, Y., & Pelton, G. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.020 · Cited by 397
Riley, K. P., Snowdon, D. A., & Markesbery, W. R. (2002) · Annals of Neurology · doi:10.1002/ana.10161 · Cited by 392
Alzheimer's Disease and Mild Cognitive Impairment
Kelley, B. J., & Petersen, R. C. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.008 · Cited by 326
Prevalence of cognitive impairment: Data from the Indianapolis Study of Health and Aging
Unverzagt, F. W., Gao, S., Baiyewu, O., Ogunniyi, A. O., Gureje, O., Perkins, A., Emsley, C. L., Dickens, J., Evans, R., Musick, B., et al. (2001) · Neurology · doi:10.1212/wnl.57.9.1655 · Cited by 312
Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study
Kuller, L. H., Shemanski, L., Manolio, T., Haan, M., Fried, L., Bryan, N., Burke, G. L., Tracy, R., & Bhadelia, R. (1998) · Stroke · doi:10.1161/01.str.29.2.388 · Cited by 310
Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease
Koch, W., Teipel, S., Mueller, S., Benninghoff, J., Wagner, M., Bokde, A. L. W., Hampel, H., Coates, U., Reiser, M., & Meindl, T. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.013 · Cited by 274
Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia
DeCarli, C., Mungas, D., Harvey, D., Reed, B., Weiner, M., Chui, H., & Jagust, W. (2004) · Neurology · doi:10.1212/01.wnl.0000130531.90205.ef · Cited by 271
Paired associate performance in the early detection of DAT
FOWLER, K. S., SALING, M. M., CONWAY, E. L., SEMPLE, & LOUIS, W. J. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617701020069 · Cited by 251
Ungar, L., Altmann, A., & Greicius, M. D. (2014) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9272-x · Cited by 246
Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999) · Psychology and Aging · doi:10.1037//0882-7974.14.2.295 · Cited by 235
Molecular biology and genetics of Alzheimer's disease
St George-Hyslop, P. H., & Petit, A. (2005) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2004.10.013 · Cited by 210
Self-citationMild Cognitive Impairment in Geriatrics
Tangalos, E. G., & Petersen, R. C. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2018.06.005 · Cited by 170
Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysis
Elias-Sonnenschein, L. S., Viechtbauer, W., Ramakers, I. H. G. B., Verhey, F. R. J., & Visser, P. J. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.231555 · Cited by 154
Welsh‐Bohmer, K. A., Gearing, M., Saunders, A. M., Roses, A. D., & Mirra, S. (1997) · Annals of Neurology · doi:10.1002/ana.410420308 · Cited by 67
Metadata
- Authors
- Tierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Tsuda, T., Chi, H., McLachlan, D. R., & St.George-Hyslop, P. H.
- Venue
- Neurology
- Published
- 1996-01
- Volume
- 46
- Issue
- 1
- Pages
- 149-154
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2037917702
- Cited by
- 144
- References
- 1
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.